Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28111918 | 0.97 | IDO1 (0.32) | IDO1 | |
| SCHEMBL50828 | 0.86 | KDM4E (0.32) | — | |
| SCHEMBL15966576 | 0.80 | — | — | |
| SCHEMBL5404962 | 0.78 | — | — | |
| SCHEMBL3353844 | 0.78 | ESR2 (0.33) | — | |
| SCHEMBL22551454 | 0.77 | IDO1 (0.32) | IDO1 | |
| SCHEMBL22551522 | 0.77 | IDO1 (0.32) | IDO1 | |
| SCHEMBL23521412 | 0.76 | — | — | |
| SCHEMBL14658322 | 0.76 | — | — | |
| SCHEMBL5420285 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111825710-B | Alkoxysilyl group-containing organosilane compound, method for producing same, composition containing same, and cured product | 信越化学工业株式会社 | 2024-08-23 | — | — | CN | disclosed |
| US-11739184-B2 | Polysiloxazane compound having alkoxysilyl group, process for producing same, and composition and cured product including same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-29 | — | — | US | disclosed |
| US-11708460-B2 | Alkoxysilyl group-containing organic silazane compound, method for producing same, composition containing same and cured product | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-07-25 | — | — | US | disclosed |
| EP-3798252-B1 | POLYSILOXAZANE COMPOUND HAVING ALKOXYSILYL GROUP, PROCESS FOR PRODUCING SAME, AND COMPOSITION AND CURED PRODUCT INCLUDING SAME | SHINETSU CHEMICAL CO (JP) | 2022-06-29 | — | — | EP | disclosed |
| US-20210095079-A1 | POLYSILOXAZANE COMPOUND HAVING ALKOXYSILYL GROUP, PROCESS FOR PRODUCING SAME, AND COMPOSITION AND CURED PRODUCT INCLUDING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-04-01 | — | — | US | disclosed |
| EP-3798252-A1 | POLYSILOXAZANE COMPOUND HAVING ALKOXYSILYL GROUP, PROCESS FOR PRODUCING SAME, AND COMPOSITION AND CURED PRODUCT INCLUDING SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-03-31 | — | — | EP | disclosed |
| CN-111825710-A | Organosilazane compounds containing alkoxysilyl groups, process for their preparation, compositions containing them and cured products | 信越化学工业株式会社 | 2020-10-27 | — | — | CN | disclosed |
| US-20200332071-A1 | ALKOXYSILYL GROUP-CONTAINING ORGANIC SILAZANE COMPOUND, METHOD FOR PRODUCING SAME, COMPOSITION CONTAINING SAME AND CURED PRODUCT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-10-22 | — | — | US | disclosed |
| EP-3725822-A1 | ALKOXYSILYL GROUP-CONTAINING ORGANIC SILAZANE COMPOUND, METHOD FOR PRODUCING SAME, COMPOSITION CONTAINING SAME AND CURED PRODUCT | Shin-Etsu Chemical Co., Ltd. (JP) | 2020-10-21 | — | — | EP | disclosed |
| EP-2835402-B1 | Formation of surface modified metal colloids | LEIBNIZ INSTITUT FUER NEUE MAT GEMEINNUETZIGE GMBH (DE) | 2020-07-08 | — | — | EP | disclosed |
| US-6743303-B2 | CONTACTING METAL SURFACE WITH ADHESION PROMOTION FORMULATION COMPRISING SULFURIC ACID AND PHOSPHORIC ACID TO FORM A MICRO-ROUGHENED CONVERSION COATED METAL SURFACE, CONTACTING WITH AQUEOUS ORGANOSILICON FORMULATION | SHIPLEY COMPANY, L.L.C. | 2004-06-01 | — | — | US | disclosed |
| US-20020132056-A1 | Contacting metal surface with adhesion promotion formulation comprising sulfuric acid and phosphoric acid to form a micro-roughened conversion coated metal surface, contacting with aqueous organosilicon formulation | SHIPLEY COMPANY, L.L.C. (US) | 2002-09-19 | — | — | US | disclosed |
| US-6147242-A | Method of producing silylalkylthiols | DEGUSSA-HULS AG (DE) | 2000-11-14 | — | — | US | disclosed |
| EP-1016668-A2 | Process for preparing silylalkylthiols | Degussa-Hüls Aktiengesellschaft (DE) | 2000-07-05 | — | — | EP | disclosed |
| EP-0471164-B1 | Process for the preparation of mercaptosilanes | HUELS CHEMISCHE WERKE AG (DE) | 1995-11-15 | — | — | EP | disclosed |
| US-5332801-A | For blends | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1994-07-26 | — | — | US | disclosed |
| US-5120800-A | Boriding with borane compound having at least one boron-hydrogen bond and oxidizing | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1992-06-09 | — | — | US | disclosed |
| US-5107009-A | PROCESS FOR THE PREPARATION OF MERCAPTOSILANES | HULS AKTIENGESELLSCHAFT (DE) | 1992-04-21 | — | — | US | disclosed |
| EP-0471164-A1 | Process for the preparation of mercaptosilanes | HÜLS AKTIENGESELLSCHAFT (DE) | 1992-02-19 | — | — | EP | disclosed |
| EP-0451819-A2 | Process for preparing modified-polyphenylene ether | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1991-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708460-B2 | Alkoxysilyl group-containing organic silazane compound, method for producing same, composition containing same and cured product | OR10J3, ALKBH1, ALKBH2 | IDO1 444/4885TRPV4 471/4885 |
| US-20200332071-A1 | ALKOXYSILYL GROUP-CONTAINING ORGANIC SILAZANE COMPOUND, METHOD FOR PRODUCING SAME, COMPOSITION CONTAINING SAME AND CURED PRODUCT | OR10J3, ALKBH1, ALKBH2 | IDO1 444/4885TRPV4 471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.